Author(s):
Wai Wai Phyo Nwe, Aye Mya Mya Thwin, Myat San Yi, Khin Than Yee, San Thitsa Aung, Ma Saung Oo, Nor Iza Binti A. Rahman, Mya Mya Thwin
Email(s):
drmyamyathwin2011@gmail.com
DOI:
10.52711/0974-360X.2021.00442 
Address:
Wai Wai Phyo Nwe1*, Aye Mya Mya Thwin3, Myat San Yi4, Khin Than Yee5, San Thitsa Aung2, Ma Saung Oo2, Nor Iza Binti A. Rahman2, Mya Mya Thwin2*
1Department of Physiology, University of Medicine, Magway, Yangon Myanmar.
2Medical Faculty, University Sultan Zainal Abidin, Kuala Terengganu, Malaysia.
3University of Medicine 1, Yangon Myanmar.
4Department of Obstretrics and Gyanecology, University of Malaysia, Sarawak.
5Department of Paraclinical Sciences, University of Malaysia, Sarawak.
*Corresponding Author
Published In:
Volume - 14,
Issue - 5,
Year - 2021
ABSTRACT:
The cardiovascular risk evidentially found to have an association with disparities of the dipper and non-dipper hypertension. There is less celerity with regard to mechanism of diurnal blood pressure variations and related disorders. The serum uric acid and AIP are considered as cardiovascular risk factors. The current study aims to determine and compare serum uric acid level and atherogenic index of plasma (AIP) in dipper and non-dipper normotensive subjects. The study population is 64 healthy normotensive subjects (32 dippers and 32 non-dippers), age between 30-55 years. The subjects were identified into dippers and non-dippers by using ambulatory blood pressure monitoring device (Spacelabs 90207, USA). After identifying dipping status of the subjects, uric acid, triglycerides and HDL cholesterol were measured. AIP was calculated by using formula (log [TG/HDL]). Median (interquartile range) of serum uric acid in the dipper group was 5.08mg/dl (4.12-5.66) and the non-dipper group was 5.27mg/dl (4.63-6.33). The median (interquartile range) for AIP was 0.24 (0.05-0.38) in the dipper group and 0.48 (0.32-0.67) in the non-dipper group. The median (interquartile range) of uric acid and AIP in the non-dipper group was significantly higher than that of dipper group (p<0.05). This study observed in even normotensive subjects, the non-dipper group has significantly higher serum uric acid and AIP than that of dipper group. These cardiovascular risk factors increased in non-dipper group compared to dipper group. The study come out with concluded that non-dipper group had higher cardiovascular risk than dipper group even in normotensive healthy subjects.
Cite this article:
Wai Wai Phyo Nwe, Aye Mya Mya Thwin, Myat San Yi, Khin Than Yee, San Thitsa Aung, Ma Saung Oo, Nor Iza Binti A. Rahman, Mya Mya Thwin. Serum Uric Acid, Lipid Profile and Atherogenic Index of Plasma in Dipper and Non-dipper Normotensive Subjects. Research Journal of Pharmacy and Technology. 2021; 14(5):2511-6. doi: 10.52711/0974-360X.2021.00442
Cite(Electronic):
Wai Wai Phyo Nwe, Aye Mya Mya Thwin, Myat San Yi, Khin Than Yee, San Thitsa Aung, Ma Saung Oo, Nor Iza Binti A. Rahman, Mya Mya Thwin. Serum Uric Acid, Lipid Profile and Atherogenic Index of Plasma in Dipper and Non-dipper Normotensive Subjects. Research Journal of Pharmacy and Technology. 2021; 14(5):2511-6. doi: 10.52711/0974-360X.2021.00442 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-5-26
REFERENCE:
1. Shimada, K., Kawamoto, A., Matsubayashi, K., Nishinaga, M. and Kimura, S. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. Journal of Hypertension. 1992; 10: p. 875-8.
2. Voros, P., Lengyel, Z. and Nagy, V. Diurnal blood pressure variation and albuminuria in normotensive patients with insulin dependent diabetes mellitus. Nephrology Dialysis Transplantation. 1998; 13: 2257-60.
3. Ohkubo, T., Imai, Y., Tsuji, I., Nagai, K., Watanabe, N. and Minami N. Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study. American Journal of Hypertension. 1997; 10: 1201-7.
4. Ohkubo, T., Imai, Y., Tsuji, I., Nagai, K., Watanabe, N., Minami, N., Itoh, O., Bando, T., Sakuma, M., Fukao, A., Satoh, H., Hisamichi and Abe, K. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. Journal of Hypertension. 1997; 15: 357-64.
5. Viera, A.J., Lin, F.C., Hinderliter, A.L., Shimbo, D., Sharina, D., Pletcher, M.J and Jacobs, D.R. Diurnal blood pressure pattern and development of prehypertension or hypertension in young adults: the CARDIA study. Hypertension. 2012: 59(6); 1157-63.
6. Biaggioni, I. Circadian clocks, autonomic rhythms and blood pressure dipping. Hypertension. 2008: 52; 797-8.
7. Bridget, B. Promoting cardiovascular health in the developing world: A critical challenge to achieve global health. Washington D.C: National Academies Press. 2010
8. Dobiasova, M. Atherogenic index of plasma [log(triglyceride/ HDL-C-Cholesterol)]: Theoretical and practical implications. Clinical Chemistry. 2014: 1113-5.
9. Sundstrom, J., Sullivan, L. and D’Agostino, R.B. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005: 45; 28–33.
10. Shankar, A., Klein, R., Klein, B.E. and Nieto, F.J. The association between serum uric acid level and long-term incidence of hypertension: population- based cohort study. Journal of Human Hypertension. 2006: 20; 937-45.
11. Grayson, P.C., Kim, S.Y., Lavalley, M. and Choi, H.K. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Research. 2011: 63; 102–10.
12. Zhou, X., Matavelli, L., Frohlich, E.D Uric acid:its relationship to renal haemodynamics and the renal rennin-angiotensin system. Current Hypertension Reports. 2006: 8; p. 120-4.
13. Sánchez-Lozada, L.G., Tapia, E., Bautista-Garcia, P. Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome. American Journal of Physiology. 2008: 294; p. F710-8.
14. Torun, D., Sezer, S., Arat,Z., Pelit, A.,Yigit, F. and Ozdemir, F.N. The frequency of combined target organ damage and the beneficial effect of ambulatory blood pressure monitoring in never treated mild to moderate hypertensive patients. International Heart Journal. 2005: 46; 1073-82.
15. Afsar, B., Elsurer, E., Nurhan, F. and Sezer, S. Uric acid and nocturnal nondipping in hypertensive patients with normal renal function. Journal of Nephrology. 2008: 21; 406-11.
16. Ferris, T.F. and Gorden, P. Effect of angiotensin and norepinephrine upon urate clearance in man. American Journal of Medicine. 1968: 44; 359 – 65.
17. Mazzali, M, Hughes, J, and Kim, Y.G. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2010: 38; 1101-6.
18. Johnson, R.J., Kang, D.H. and Feig, D. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003: 41; 1183-90.
19. Dobiasova, M. AIP- atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitrni Lekarstvi. 2006: 52(1); 64-71.
20. Baliarsingh, S., Sharma, N. and Mukherjee, R. Serum uric acid: Marker for atherosclerosis as it is positively associated with “Atherogenic index of plasma. Archives of Physiology and Biochemistry. 2013: 119(1); 27–31.
21. Tinahones, F.J., Soriguer, F.J., Collantes, E., Perez-Lindon, G., Sanchez, G.P. and Lillo, J.A. Decreased triglyceride levels with low calorie diet and increased renal excretion of uric acid in hyperuricaemic-hyperlipidaemic patients. Annals of Rheumatic Diseases. 1995: 54; 609-10.